Interactions between major histocompatibility complex class II surface expression and HIV: Implications for pathogenesis

European Journal of Clinical Investigation

Volumn 31, Issue 11, 2001, Pages 984-991

  Kamp, W ^a   Breij, E C W ^b   Nottet, H S L M ^b   Berk, M B ^b,c  

^a Fight for Life Foundation   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Gp120; HIV; MHC II; Tat

Indexed keywords

HLA DR ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; VIRUS ENVELOPE PROTEIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANTIGEN EXPRESSION; ARTICLE; BRAIN; CELL LINE; DOWN REGULATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; MACROPHAGE; MOLECULAR INTERACTION; MONOCYTE; NONHUMAN; PRIORITY JOURNAL; REGULATORY MECHANISM; TISSUE DISTRIBUTION; VIRION; VIRUS INFECTIVITY; VIRUS PARTICLE; VIRUS PATHOGENESIS; VIRUS REPLICATION;

ACQUIRED IMMUNODEFICIENCY SYNDROME; BRAIN; DOWN-REGULATION; GENES, MHC CLASS II; HISTOCOMPATIBILITY ANTIGENS CLASS II; HIV INFECTIONS; HIV-1; HUMANS; MACROPHAGES; MONOCYTES; UP-REGULATION;

EID: 0035780251     PISSN: 00142972     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2362.2001.00895.x     Document Type: Article

References (68)

1. MacDonald KS, Fowke KR, Kimai J, Dunand A, Nagelkerke NJD, Ball TB et al. Influence of HLA supertypes on susceptibility and resistance to human immunodeficiency virus type 1 infection. J Infect Dis 2000;181:1581-9.
2. MacDonald K, Embree J, Njenga S Nagelkerke NJ, Ngatia I, Mohommed Z et al. Mother-child class I HLA concordance increases perinatal human immunodeficiency virus type 1 transmission. J Infect Dis 1998;177:551-6.
3. Hendel H, Caillat-Zucman S, Lebuanec H, Carrington M, O'Brien S, Andrieu J et al. New Class I and II HLA alleles strongly associated with opposite patterns of progression to AIDS. J Immunol 1999;162:6942-6.
4. Candore G, Romano GC, D'Anna C, Di Lorenzo G, Gervasi F, Lio D et al. Biological basis ot ht HLA-B8-DR3-associated progression of acquired immunodeficiency syndrome. Pathobiology 1998;66:33-7.
5. Kaplan C, Muller IY, Doinel C, Lefrere JJ, Paquez F, Rouger P, et al. HLA-associated susceptibility of acquired immunodeficiency syndrome in HIV-1-seropositive subjects. Hum Hered 1990;40:290-8.
6. Cruse JM, Brackin MN, Lewis RE, Meeks W, Rolan R, Brackin B. HLA disease association and protection in HIV infection among African Americans and Caucasions. Pathobiology 1991;59:324.
7. Tang J, Costello C, Keet IP, Rivers C, Leblanc S, Karita E et al. HLA class I homozygosity accelerates disease progression in human immunodefiicency virus type 1 infection. AIDS Res Human Retroviruses 1999;15:317-24.
8. Johnson RP, Siliciano RF, McElrath MJ. Cellular immune responses to HIV-1. AIDS 1998;12 (Suppl. A):S113-S120.
9. Collins KL, Baltimore D. HIV's evasion of the cellular immune response. Immunol Rev 1999;168:65-74.
10. Kamp W, Berk MB, Visser CJT, Nottet HSLM. Mechanisms of HIV-1 to escape from the host immune surveillance. Eur J Clin Invest 2000;30:740-6.
11. Abel PM, McSharry C, Galloway E, Ross C, Severn A, Toner G et al. Heterogeneity of perihperal blood monocyte populations in human immunodeficiency virus-1 seropostivie patients. FEMS Immunol Med Microbiol 1992;5:317-23.
12. Koethe SM, Carrigan DR, Turner PA. Increased density of HLA-DR antigen on monocytes of patients infected with the human immunodeficiency virus. J Med Virol 1989;29:82-7.
13. Locher C, Vanham G, Kestens L, Kruger M, Ceuppens JL, Vingerhoets J et al. Expression patterns of Fc gamma receptors, HLA-DR and selected adhesion molecules on monocytes from normal and HIV-infected individuals. Clin Exp Immunology 1994;98:115-22.
14. Heagy W, Kelley VE, Strom TB, Mayer K, Shapiro HM, Mandel R et al. Decreased expression of human class II antigens on monocytes from patients with acquired immunodeficiency syndrome. J Clin Invest 1984;74:2089-96.
15. Roy G, Rojo N, Leyva-Cobian F. Phenotypic changes in monocytes and alveolar macrophages in patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related complex (ARC). J Clin Lab Immunol 1987;23:135-41.
16. Braun DP, Kessler H, Falk L, Paul D, Harris JE, Blaauw B et al. Monocyte funtional studies in asymptomatic human immunodeficiency virus (HIV) -infected individuals. J Clin Immunol 1988;8:486-94.
17. Zwilling BS, Salkowitz J, Laufman H, Pearl D. Differences in the expression of histocompatibility antigen-DR and in ant-Mycobacterial activity of monocytes from HIV-infected individuals. AIDS 1991;5:1327-13.
18. Haas JG, Riethmuller G, Ziegler-Heitbrock HW. Monocyte phenotype and function in patients with the acquired immunodeficiency syndrome (AIDS) and AIDS-related disorders. Scand J Immunol 1987;26:371-9.
19. Petit AJ, Terpstra FG, Miedema F. Human immunodeficiency virus infection down-regulates HLA class II expression and induces differentation in promonocytic U937 cells. J Clin Invest 1987;79:1883-9.
20. Polyak S, Chen H, Hirsch D, George I, Hershberg R, Sperber K. Impaired class II expression and antigen uptake in monocytic cells after HIV-1 infection. J Immunol 1997;159:2177-88.
21. Kanazawa S, Okamoto T, Peterlin BM. Tat competes with CIITA for the binding to P-TEFb and blocks the expression of MHC Class II genes in HIV infection. Immunity 2000;12:61-70.
22. Mann DL, Gartner S, LeSane F, Blattner WA, Popovic M. Cell surface antigens and function of monocytes and monocyte-like cell line before and after infection with HIV. Clin Immunol Immunopathol 1990;54:174-83.
23. Crowe SM, Kornbluth RS. Overview of HIV interactions with macrophages and dendritic cells: The other infection in AIDS. J Leukoc Biol 1994;56:215-7.
24. Valentin A, Nilsson K, Asjo B. Tropism for primary moncytes and for monocytoid cell lines are separate features of HIV-1 variants. J Leukoc Biol 1994;225:225-9.
25. Paul WE. Fundamental Immunology, 3rd edn. Raven Press, New York, 1993.pp.000.
26. Meyaard L, Schuitemaker H, Miedema F. T-cell dysfunction in HIV infection: Anergy due to defective antigen-presenting cell function? Immunol Today 1993;14:161-4.
27. Fuchs D, Hausen A, Reibnegger G, Werner ER, Werner-Felmayer G, Dierich MP et al. Interferon-gamma concentrations are increased in sera from individuals infected with human immunodeficiency virus type 1. J Acquir Immune Defic Syndr 1989;2:185-62.
28. Fan J, Bass HZ, Fahey JL. Elevated IFN-gamma and decreased IL-2 gene expression are associated with HIV infection. J Immunol 1993;151:5031-40.
29. Baldwin GC, Fleischmann J, Chung Y, Koyanagi Y, Chen ISY, Golde DW. Human immunodeficiency cirus causes mononuclear phagocytee dysfunction. Proc Natl Acad Sci USA 1990;87:3933-7.
30. Tortorella D, Gewurz BE, Furman MH, Schust DJ, Ploegh HL. Viral subversion of the immune system. Annu Rev Immunol 2000;18:861-926.
31. Saifuddin M, Roebuck KA, Chang C, Ting JPY, Spear G. Cutting edge, activation of HIV-1 transcription by the MHC Class II transactivator. J Immunol 2000;164:3941-5.
32. Zembala M, Bach S, Szczepanek A, Mancino G, Cloizzi V. Phenotypic changes of monocytes induced by HIV-1 gp120 molecule and its fragments. Immunobiology 1997;197:110-21.
33. Durrbaum-Landmann I, Kaltenhauser E, Flad HD, Ernst M. HIV-1 envelope protein gp120 affects phenotype and function of monocytes in vitro. J Leukoc Biol 1994;55:545-51.
34. Schols D, De Clerq E. Human immunodeficiency virus type 1 gp120 induced anergy in human peripheral blood lymphocytes by inducing interleukin-10 production. J Virol 1996;70:4953-60.
35. Oh SK, Cruikshank WW, Raina J, Blanchard GC, Adler WH, Walker J et al. Identification of HIV-1 glycoprotein in the serum of AIDS and ARC patients. J Aquir Immune Defic Syndr 1992;5:251.
36. Navia BA, Cho E-S, Petto CK, Price RW. The AIDS dementia complex. I. Clinical features. Ann Neurol 1986;19:517-24.
37. Price RW, Brew B, Sidtis J, Rosenblum M, Scheck AC, Cleary P. The brain in AIDS, central nervous system HIV-1 infection and AIDS dementia complex. Science 1988;239:586-92.
38. Glass JD, Johnson RT. Human immunodeficiency virus and the brain. Annu Rev Neurosci 1996;19:1-26.
39. Nottet HSLM, Gendelman HE. Unraveling the neuroimmune mechanisms for the HIV-1 associated cognitive/motor complex. Immunol Today 1995;16:441-8.
40. Achim CL, Morey MK, Clayton AW. Expression of major histocompatibility complex and HIV antigens within the brains of AIDS patients. AIDS 1991;5:535-41.
41. An SF, Ciardi A, Giometto B, Scaravilli T, Gray F, Scaravilli F. Investigation on the expression of major histocompatibility complex class II and cytokines and detection of HIV-1 DNA within brains of asymptomatic and symptomatic HIV-1-positive patients. Acta Neuropathol 1996;91:494-503.
42. Dallasta LM, Pisarov LA, Esplen JE, Werly JV, Moses AV, Nelson JA et al. Blood-brain barrier tight junction disruption in human immunodeficiency virus-1 encephalitis. Am J Pathol 1999;155:1915-27.
43. Kennedy PG, Gairns J 1992 Major histocompatibility complex (MHC) antigen expression in HIV encephalitis. Neuropathol Appl Neurobiol 1999;18:515-22.
44. Persidsky Y, Stins M, Way D, Witte MH, Weinand M, Kim KS et al. A model for monocyte migration through the blood-brain barrier during HIV-1 encephalitis. J Immunol 1997;158:3499-510.
45. Buhl R, Jaffe HA, Holroyd KJ, Borok Z, Roum JH, Mastrangeli A et al. Activation of alveolar macrophages in asymptomatic HIV-infected individuals. J Immunol 1993;150:1019-28.
46. Lipman MCI, Johnson MA, Poulter LH. Changes to alveolar macrophage phenotype in HIV infected individuals with normal CD4 counts and no respiratory disease. Thorax 1995;50:777-81.
47. Vilcek J, Lee TH. Tumor necrosis factor. Journal of Biol Chem 1991;266:7313.
48. Wahl LM, Corcoran ML, Pyle SW, Arthur LO, Hanel-Bellan A, Farrar WL. Human immunodeficiency virus glycoprotein (gp120) induction of monocyte arachidonic acid metabolites and interleukin 1. Proc Natl Acad Sci USA 1989;86:621.
49. Wahl SM, Allen JB, Gartner S, Orenstein JM, Popvic M, Chenoweth DE et al. HIV and its envelope glycoprotein downregulate chemotactic ligand receptors and chemotactic function of peripheral blood monocytes. J Immunol 1989;142:3553.
50. Arthur LO, Bess JW Jr, Sowder RC II, Benveniste RE, Mann DL, Chermann J-C et al. Cellular proteins bound to immunodeficiency viruses: implications for pathogenesis and vaccines. Science 1992;258:1935-38.
51. Schols D, Pauwels R, Desmyter J, De Clerk E. Presence of class II histocompatibility DR proteins on the envelope of human immunodeficiency virus demonstrated by FACS analysis. Virology 1992;189:374-6.
52. Tsai WP, Kung HF, Nara PL. The presence and absence of histocompatibility antigens in HIV type 1 produced by autologous blood-derived macrophages and peripheral blood lymphoblasts. AIDS Res Human Retroviruses 1999;15:33-41.
53. Orentas RJ, Hildreth JEK. Association of host cell surface adhesion receptors and other membrane proteins with HIV and SIV. AIDS Res Human Retroviruses 1993;9:131-7.
54. Cantin R, Fortin J, Tremblay M. The amount of host HLA-DR proteins acquired by HIV-1 is virus strain- and cell type-specific. Virology 1996;218:372-81.
55. Cantin R, Fortin F, Lamontagne G, Tremblay M. The acquisition of host-derived major histocompatibility complex class II glycoproteins by human immunodeficiency virus type 1 accelerates the process of virus entry and infection in human T-lymphoid cells. Blood 1997;90:1091-100.
56. Cantin R, Fortin F, Lamontagne G, Tremblay M. The presence of host-derived HLA-DR1 on human immunodeficiency virus type 1 increases viral infectivity. J Virol 1997;71:1922-30.
57. Arthur LO, Bess JWJ, Urban RG, Strominger JL, Morton WR, Mann DL et al. Macaques immunized with HLA-DR are protected from challenge with simian immunodeficiency virus. J Virol 1995;69:3117.
58. Fleury S, Thibodeau J, Croteau G, Labrecque N, Aronson H, Cantin C et al. HLA-DR polymorphism affects the interaction with CD4. J Exp Med 1995;182:807-22.
59. Lawn SD, Butera ST. Incorporation of HLA-DR into the envelope of human immunodeficiency virus type 1 in vivo: Correlation with stage of disease and presence of opportunistic infection. J Virol 2000;74:10256-9.
60. Salazar-Gonzalez JF, Martinez Maza O, Nishanian P, Aziz N, Shen LP, Grosser S et al. Increased immune activation precedes the inflection point of CD4 T cells and the increased serum virus load in human immunodeficiency virus infection. J Infect Dis 1998;178:423-30.
61. Lawn SD, Rudolph D, Wiktor S, Coulibaly D, Ackah A, Lal RB. Tuberculosis and HIV infection are independently associated with elevated serum concentrations of tumor necrosis factor receptor type 1 and $2-microglobulin, respectively. Clin Exp Immunol 2000;122:79-84.
62. Sulkowski MS, Chaisson RE, Karp CL, Moore RD, Margolick JB, Quinn TC. The effect of acute infectious illnesses on plasma human immunodeficiency virus type I load and the expression of serologic markers of the immune activation among HIV-infected adults. J Infect Dis 1998;178:1642-48.
63. Vanham G, Edmonds K, Qing L, Hom D, Toosi Z, Jones B et al. Generalised immune activation in pulmonary tuberculosis: Coactivation with HIV infection. Clin Exp Immunol 1996;103:30-4.
64. Janeway CA, Travers P. Immunobiology, 2nd edn. Current Biology Ltd, London and Garland Publishing Inc., New York, 1996.pp.7:16.
65. Poon DTK, Coren LV, Ott DE. Efficient incorporation of HLA class II onto human immunodeficiency virus type 1 requires envelope glycoprotein packaging. J Virol 2000;74;3918-23.
66. Ashworth LA, Hall GA, Sharpe SA, Dennis MJ, Thornton C, Cook RWet al. Constitutive expression of major histocompatibility complex class II antigens on monocytes and B cells correlates with disease in simian immunodeficiency virus-infected rhesus macaques. J Infect Dis 1995;172:1261-67.
67. Miller DM, Rahill BM, Boss JM, Lairmore MD, Durbin JE, Waldman WJ et al. Human cytomegalovirus inhibits major histocompatibility complex class II expression by disruption of the Jak/Stat pathway. J Exp Med 1998;187:675-83.
68. Gercken J, Pryjma J, Ernst M, Flad HD. Defective antigen presentation by mycobacterium tuberculosis-infected moncytes. Infection and Immunity 1994;62:3472-8.